Citations (151)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qing Xu, Sen Lin, Qian Li, Yaqiu Lin, Yan Xiong, Jiangjiang Zhu & Yong Wang. (2021) Fibroblast growth factor 21 regulates lipid accumulation and adipogenesis in goat intramuscular adipocyte. Animal Biotechnology 32:3, pages 318-326.
Read now
Read now
Elke Burgermeister, Teresa Friedrich, Ivana Hitkova, Ivonne Regel, Henrik Einwächter, Wolfgang Zimmermann, Christoph Röcken, Aurel Perren, Matthew B. Wright, Roland M. Schmid, Rony Seger & Matthias P. A. Ebert. (2011) The Ras Inhibitors Caveolin-1 and Docking Protein 1 Activate Peroxisome Proliferator-Activated Receptor γ through Spatial Relocalization at Helix 7 of Its Ligand-Binding Domain. Molecular and Cellular Biology 31:16, pages 3497-3510.
Read now
Read now
Suheyla Gorar, Cavit Culha, Ziynet Alphan Uc, Fatma Dilek Dellal, Rustu Serter, Sema Aral & Yalcin Aral. (2010) Serum fibroblast growth factor 21 levels in polycystic ovary syndrome. Gynecological Endocrinology 26:11, pages 819-826.
Read now
Read now
Cecile Vernochet, Sidney B. Peres, Kathryn E. Davis, Meghan E. McDonald, Li Qiang, Hong Wang, Philipp E. Scherer & Stephen R. Farmer. (2009) C/EBPα and the Corepressors CtBP1 and CtBP2 Regulate Repression of Select Visceral White Adipose Genes during Induction of the Brown Phenotype in White Adipocytes by Peroxisome Proliferator-Activated Receptor γ Agonists. Molecular and Cellular Biology 29:17, pages 4714-4728.
Read now
Read now
Articles from other publishers (147)
Marleen Würfel, Matthias Blüher, Michael Stumvoll, Thomas Ebert, Peter Kovacs, Anke Tönjes & Jana Breitfeld. (2023) Adipokines as Clinically Relevant Therapeutic Targets in Obesity. Biomedicines 11:5, pages 1427.
Crossref
Crossref
Ming-Hui Cheng, Wen-Ya Zheng, Quan-Quan Zhang, Zhu Liu, Jing-Fang Chen, Mahnoor Atta & Hong Qin. (2023) Sesamol promotes browning of white adipocytes through liver-adipose crosstalk signal of hepatic fibroblast growth factor 21. The Journal of Nutritional Biochemistry 115, pages 109278.
Crossref
Crossref
Shivangi Patel, Hasnat Khan & Anuradha Majumdar. (2022) Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy. Metabolic Brain Disease 37:7, pages 2181-2195.
Crossref
Crossref
Redin A. Spann, Christopher D. Morrison & Laura J. den Hartigh. (2022) The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model. Frontiers in Endocrinology 12.
Crossref
Crossref
Simona Cataldi, Valerio Costa, Alfredo Ciccodicola & Marianna Aprile. (2021) PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine. Current Diabetes Reports 21:6.
Crossref
Crossref
Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín & Valmore Bermúdez. (2021) Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. International Journal of Molecular Sciences 22:9, pages 4807.
Crossref
Crossref
Yin-Zhao Jia, Qiao-Juan Mei & Yong Zhang. (2021) MiR-484 participates in non-alcoholic fatty liver injury by targeting SIRT1 to mediate cell apoptosis. World Chinese Journal of Digestology 29:8, pages 389-397.
Crossref
Crossref
Ricardo Moure, Montserrat Cairó, Samantha Morón-Ros, Tania Quesada-López, Laura Campderrós, Rubén Cereijo, Alvaro Hernáez, Francesc Villarroya & Marta Giralt. (2021) Levels of β-klotho determine the thermogenic responsiveness of adipose tissues: involvement of the autocrine action of FGF21. American Journal of Physiology-Endocrinology and Metabolism 320:4, pages E822-E834.
Crossref
Crossref
Hui Sun, Matthew Sherrier & Hongshuai Li. (2021) Skeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21. Frontiers in Physiology 12.
Crossref
Crossref
Sérgio Henrique Sousa Santos, Victor Hugo Dantas Guimarães, Janaina Ribeiro Oliveira & Luiz Fernando Rezende. 2021. Sirtuin Biology in Cancer and Metabolic Disease. Sirtuin Biology in Cancer and Metabolic Disease
39
59
.
Yingzhe Xiong, Yan Chen, Yao Liu & Bing Zhang. (2020) Moderate-Intensity Continuous Training Improves FGF21 and KLB Expression in Obese Mice. Biochemistry (Moscow) 85:8, pages 938-946.
Crossref
Crossref
Åsmund Kaupang & Trond Vidar Hansen. (2020)
The PPAR
Ω
Pocket: Renewed Opportunities for Drug Development
. PPAR Research 2020, pages 1-21.
Crossref
Crossref
Violina Kakoty, Sarathlal K C, Ruei-Dun Tang, Chih Hao Yang, Sunil Kumar Dubey & Rajeev Taliyan. (2020) Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease. Biomedicine & Pharmacotherapy 127, pages 110145.
Crossref
Crossref
Zhilin Ma, Jian Xu, Limei Wu, Junjie Wang, Qiqi Lin, Fabliha A. Chowdhury, Md. Habibul H. Mazumder, Gangqing Hu, Xue Li & Wei Du. (2020)
Hes1
deficiency causes hematopoietic stem cell exhaustion
. Stem Cells 38:6, pages 756-768.
Crossref
Crossref
Hongshuai Li, Hui Sun, Baoli Qian, Wei Feng, Dwayne Carney, Jennifer Miller, MaCalus V Hogan & Ling Wang. (2019) Increased Expression of FGF‐21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout Mice. Journal of Bone and Mineral Research 35:4, pages 738-752.
Crossref
Crossref
Sebastio Perrini, Stefania Porro, Pasquale Nigro, Angelo Cignarelli, Cristina Caccioppoli, Valentina Annamaria Genchi, Gennaro Martines, Michele De Fazio, Palma Capuano, Annalisa Natalicchio, Luigi Laviola & Francesco Giorgino. (2019) Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity. International Journal of Obesity 44:2, pages 307-319.
Crossref
Crossref
Yongde Luo, Yaying Yang, Muyun Liu, Dan Wang, Feng Wang, Yawei Bi, Juntao Ji, Suyun Li, Yan Liu, Rong Chen, Haojie Huang, Xiaojie Wang, Agnieszka K. Swidnicka-Siergiejko, Tobias Janowitz, Semir Beyaz, Guoqiang Wang, Sulan Xu, Agnieszka B. Bialkowska, Catherine K. Luo, Christoph L. Pin, Guang Liang, Xiongbin Lu, Maoxin Wu, Kenneth R. Shroyer, Robert A. Wolff, William Plunkett, Baoan Ji, Zhaoshen Li, Ellen Li, Xiaokun Li, Vincent W. Yang, Craig D. Logsdon, James L. Abbruzzese & Weiqin Lu. (2019) Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet. Gastroenterology 157:5, pages 1413-1428.e11.
Crossref
Crossref
Xiaokun Li. (2019) The FGF metabolic axis. Frontiers of Medicine 13:5, pages 511-530.
Crossref
Crossref
Christine J. Pol, Nina M. Pollak, Michael J. Jurczak, Effimia Zacharia, Iordanes Karagiannides, Ioannis D. Kyriazis, Panagiotis Ntziachristos, Diego A. Scerbo, Brett R. Brown, Iannis Aifantis, Gerald I. Shulman, Ira J. Goldberg & Konstantinos Drosatos. (2019) Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865:9, pages 2125-2137.
Crossref
Crossref
Virag Vas, Tamás Háhner, Gyöngyi Kudlik, Dávid Ernszt, Krisztián Kvell, Dániel Kuti, Krisztina J. Kovács, József Tóvári, Mária Trexler, Balázs L. Merő, Bálint Szeder, Kitti Koprivanacz & László Buday. (2019) Analysis of Tks4 Knockout Mice Suggests a Role for Tks4 in Adipose Tissue Homeostasis in the Context of Beigeing. Cells 8:8, pages 831.
Crossref
Crossref
Caterina Tezze, Vanina Romanello & Marco Sandri. (2019) FGF21 as Modulator of Metabolism in Health and Disease. Frontiers in Physiology 10.
Crossref
Crossref
Michelle Chan, Yen Ching Lim, Jing Yang, Maria Namwanje, Longhua Liu & Li Qiang. (2019) Identification of a natural beige adipose depot in mice. Journal of Biological Chemistry 294:17, pages 6751-6761.
Crossref
Crossref
B. S. Yurekli, N. O. Kutbay, M. Aksit, A. Suner, I. Y. Simsir, S. Seckiner, G. U. Kocabas, G. Bozkaya & F. Saygili. (2018) Acromegaly is associated with high fibroblast growth factor-21 levels. Journal of Endocrinological Investigation 42:1, pages 53-60.
Crossref
Crossref
Ricardo Moure, Pere Domingo, Joan Villarroya, Laura Gasa, José M. Gallego-Escuredo, Tania Quesada-López, Samantha Morón-Ros, Alberto F. Maroto, Gracia M. Mateo, Joan C. Domingo, Francesc Villarroya & Marta Giralt. (2018) Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/β-Klotho System. Antimicrobial Agents and Chemotherapy 62:6.
Crossref
Crossref
Masakazu Kikai, Hiroyuki Yamada, Noriyuki Wakana, Kensuke Terada, Keita Yamamoto, Naotoshi Wada, Shinichiro Motoyama, Makoto Saburi, Takeshi Sugimoto, Daisuke Irie, Taku Kato, Hiroyuki Kawahito, Takehiro Ogata & Satoaki Matoba. (2018)
Retracted: Transplantation of brown adipose tissue inhibits atherosclerosis in
apoE−/−
mice: contribution of the activated FGF-21-adiponectin axis
. Cardiovascular Research 114:6, pages i1-i13.
Crossref
Crossref
Masakazu Kikai, Hiroyuki Yamada, Noriyuki Wakana, Kensuke Terada, Keita Yamamoto, Naotoshi Wada, Shinichiro Motoyama, Makoto Saburi, Takeshi Sugimoto, Daisuke Irie, Taku Kato, Hiroyuki Kawahito, Takehiro Ogata & Satoaki Matoba. (2018) Adrenergic receptor-mediated activation of FGF-21-adiponectin axis exerts atheroprotective effects in brown adipose tissue-transplanted apoE mice. Biochemical and Biophysical Research Communications 497:4, pages 1097-1103.
Crossref
Crossref
Xueying Li, Yan Wang, Jiazhong Guo, Tao Zhong, Li Li, Hongping Zhang & Linjie Wang. (2018) Identification and expression patterns of adipokine genes during adipocyte differentiation in the Tibetan goat ( Capra hircus ). Gene 643, pages 17-25.
Crossref
Crossref
Xiaokun Li. 2018. Fibroblast Growth Factors. Fibroblast Growth Factors
217
313
.
Hsiu-Chu Chou, Li-Li Wen, Chih-Cheng Chang, Chien-Yu Lin, Lu Jin & Shu-Hui Juan. (2017) From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate. Toxicological Sciences 160:2, pages 217-229.
Crossref
Crossref
Dongjoo You, Emma Nilsson, Danielle E Tenen, Anna Lyubetskaya, James C Lo, Rencong Jiang, Jasmine Deng, Brian A Dawes, Allan Vaag, Charlotte Ling, Evan D Rosen & Sona Kang. (2017) Dnmt3a is an epigenetic mediator of adipose insulin resistance. eLife 6.
Crossref
Crossref
Junco Shibayama Warren, Shin-ichi Oka, Daniela Zablocki & Junichi Sadoshima. (2017) Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics. American Journal of Physiology-Heart and Circulatory Physiology 313:3, pages H584-H596.
Crossref
Crossref
Ruidong Xiang, Iona M. MacLeod, Sunduimijid Bolormaa & Michael E. Goddard. (2017) Genome-wide comparative analyses of correlated and uncorrelated phenotypes identify major pleiotropic variants in dairy cattle. Scientific Reports 7:1.
Crossref
Crossref
Kai Cai, Rabih El-Merahbi, Mona Loeffler, Alexander E. Mayer & Grzegorz Sumara. (2017) Ndrg1 promotes adipocyte differentiation and sustains their function. Scientific Reports 7:1.
Crossref
Crossref
Xiaolong Lin, Yuan Bo Liu & Huijun Hu. (2017) Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues. Biomedical Reports 6:5, pages 495-502.
Crossref
Crossref
Daniel Cuevas-Ramos & Carlos A. Aguilar-Salinas. (2017) Modulation of energy balance by fibroblast growth factor 21. Hormone Molecular Biology and Clinical Investigation 30:1.
Crossref
Crossref
Anjeza Erickson & Régis Moreau. (2017)
The regulation of
FGF21
gene expression by metabolic factors and nutrients
. Hormone Molecular Biology and Clinical Investigation 30:1.
Crossref
Crossref
Ahmed Khalil, Mikhail Parker, Richard Mpanga, Sebnem E. Cevik, Cassandra Thorburn & Alexander Suvorov. (2017) Developmental Exposure to 2,2′,4,4′–Tetrabromodiphenyl Ether Induces Long-Lasting Changes in Liver Metabolism in Male Mice. Journal of the Endocrine Society 1:4, pages 323-344.
Crossref
Crossref
Dandan Guan, Lidan Zhao, Daiwen Chen, Bing Yu & Jie Yu. (2016) Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state. Journal of Translational Medicine 14:1.
Crossref
Crossref
Hong Wang, Libin Liu, Jean Z. Lin, Tamar R. Aprahamian & Stephen R. Farmer. (2016) Browning of White Adipose Tissue with Roscovitine Induces a Distinct Population of UCP1 + Adipocytes. Cell Metabolism 24:6, pages 835-847.
Crossref
Crossref
Thereza Cristina Lonzetti Bargut, Marcia Barbosa Aguila & Carlos Alberto Mandarim-de-Lacerda. (2016) Brown adipose tissue: Updates in cellular and molecular biology. Tissue and Cell 48:5, pages 452-460.
Crossref
Crossref
Yue Yu, Ning Zhang, Heng Jiang, Wei Xue, Xinhui Guo, Xiaoling Xu, Weichun Fang, Hao Wang & Erbing Hua. (2016) Resveratrol treatment improves plasma and blood glucose concentration and lipid metabolism in high-fat-fed C57BL/6J mice. European Food Research and Technology 242:11, pages 1849-1856.
Crossref
Crossref
Christine M. Kusminski, Perry E. Bickel & Philipp E. Scherer. (2016) Targeting adipose tissue in the treatment of obesity-associated diabetes. Nature Reviews Drug Discovery 15:9, pages 639-660.
Crossref
Crossref
Yong Zhou, Ying Wu, Yu Qin, Lei Liu, Jing Wan, Lingyun Zou, Qianyong Zhang, Jundong Zhu & Mantian Mi. (2016) Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway. PLOS ONE 11:7, pages e0159191.
Crossref
Crossref
Giovanni Musso, Maurizio Cassader & Roberto Gambino. (2016) Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nature Reviews Drug Discovery 15:4, pages 249-274.
Crossref
Crossref
Mengna Xia, Anjeza Erickson, Xiaohua Yi & Régis Moreau. (2016) Mapping the response of human fibroblast growth factor 21 (FGF21) promoter to serum availability and lipoic acid in HepG2 hepatoma cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:3, pages 498-507.
Crossref
Crossref
Thomas Arbogast, Abdel-Mouttalib Ouagazzal, Claire Chevalier, Maksym Kopanitsa, Nurudeen Afinowi, Eugenia Migliavacca, Belinda S. Cowling, Marie-Christine Birling, Marie-France Champy, Alexandre Reymond & Yann Herault. (2016) Reciprocal Effects on Neurocognitive and Metabolic Phenotypes in Mouse Models of 16p11.2 Deletion and Duplication Syndromes. PLOS Genetics 12:2, pages e1005709.
Crossref
Crossref
Peng Cheng, Fangfang Zhang, Lechu Yu, Xiufei Lin, Luqing He, Xiaokun Li, Xuemian Lu, Xiaoqing Yan, Yi Tan & Chi Zhang. (2016) Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases. Journal of Diabetes Research 2016, pages 1-8.
Crossref
Crossref
Chiara Degirolamo, Carlo Sabbà & Antonio Moschetta. (2015) Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nature Reviews Drug Discovery 15:1, pages 51-69.
Crossref
Crossref
Marta Giralt, Aleix Gavaldà-Navarro & Francesc Villarroya. (2015) Fibroblast growth factor-21, energy balance and obesity. Molecular and Cellular Endocrinology 418, pages 66-73.
Crossref
Crossref
Maitea GuridiLionel A. TintignacShuo LinBarbara KuprPerrine CastetsMarkus A. Rüegg. (2015) Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21. Science Signaling 8:402.
Crossref
Crossref
Mingxun Li, Xiaomei Sun, Yang Zhou, Xuefeng Wei, Yujia Sun, Xianyong Lan, Chuzhao Lei & Hong Chen. (2015) Nicotinamide and resveratrol regulate bovine adipogenesis through a SIRT1-dependent mechanism. Journal of Functional Foods 18, pages 492-500.
Crossref
Crossref
Takeshi Inagaki. (2015) Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD. Frontiers in Endocrinology 6.
Crossref
Crossref
Eleni M. DomouzoglouKaterina K. NakaAntonios P. VlahosMichail I. PapafaklisLampros K. MichalisAgathoklis TsatsoulisEleftheria Maratos-Flier. (2015) Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21. American Journal of Physiology-Heart and Circulatory Physiology 309:6, pages H1029-H1038.
Crossref
Crossref
R. Ringseis, D. K. Gessner & K. Eder. (2015) Molecular insights into the mechanisms of liver-associated diseases in early-lactating dairy cows: hypothetical role of endoplasmic reticulum stress. Journal of Animal Physiology and Animal Nutrition 99:4, pages 626-645.
Crossref
Crossref
Miwa Suzuki, Andrew Y. Lee, José Pablo Vázquez-Medina, Jose A. Viscarra, Daniel E. Crocker & Rudy M. Ortiz. (2015) Plasma FGF21 concentrations, adipose fibroblast growth factor receptor-1 and β-klotho expression decrease with fasting in northern elephant seals. General and Comparative Endocrinology 216, pages 86-89.
Crossref
Crossref
Rafael Mayoral, Olivia Osborn, Joanne McNelis, Andrew M. Johnson, Da Young Oh, Cristina Llorente Izquierdo, Heekyung Chung, Pingping Li, Paqui G. Traves, Gautam Bandyopadhyay, Ariane R. Pessentheiner, Jachelle M. Ofrecio, Joshua R. Cook, Li Qiang, Domenico Accili & Jerrold M. Olefsky. (2015) Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity. Molecular Metabolism 4:5, pages 378-391.
Crossref
Crossref
Wen-Fei Wang, Si-Ming Li, Gui-Ping Ren, Wei Zheng, Yu-Jia Lu, Yin-Hang Yu, Wen-Juan Xu, Tian-He Li, Li-Hong Zhou, Yan Liu & De-Shan Li. (2014) Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats. Endocrine 49:1, pages 119-129.
Crossref
Crossref
Matthew P. Gilbert & Richard E. Pratley. (2015) The Impact of Diabetes and Diabetes Medications on Bone Health. Endocrine Reviews 36:2, pages 194-213.
Crossref
Crossref
Anne-Laure Poher, Jordi Altirriba, Christelle Veyrat-Durebex & Françoise Rohner-Jeanrenaud. (2015) Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance. Frontiers in Physiology 6.
Crossref
Crossref
Francesc Ribas, Joan Villarroya, Elayne Hondares, Marta Giralt & Francesc Villarroya. (2014) FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signalling. Biochemical Journal 463:2, pages 191-199.
Crossref
Crossref
Santiago Vernia, Julie Cavanagh-Kyros, Luisa Garcia-Haro, Guadalupe Sabio, Tamera Barrett, Dae Young Jung, Jason K. Kim, Jia Xu, Hennady P. Shulha, Manuel Garber, Guangping Gao & Roger J. Davis. (2014) The PPARα-FGF21 Hormone Axis Contributes to Metabolic Regulation by the Hepatic JNK Signaling Pathway. Cell Metabolism 20:3, pages 512-525.
Crossref
Crossref
Xingguo Cheng, Saurabh G. Vispute, Jie Liu, Christine Cheng, Alexei Kharitonenkov & Curtis D. Klaassen. (2014) Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR). Toxicology and Applied Pharmacology 278:1, pages 65-71.
Crossref
Crossref
Alexei Kharitonenkov & Andrew C. Adams. (2014) Inventing new medicines: The FGF21 story. Molecular Metabolism 3:3, pages 221-229.
Crossref
Crossref
Jun Zhang & Yang Li. (2014) Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome. Drug Discovery Today 19:5, pages 579-589.
Crossref
Crossref
Rebecca L. Scalzo, Garrett L. Peltonen, Gregory R. Giordano, Scott E. Binns, Anna L. Klochak, Hunter L. R. Paris, Melani M. Schweder, Steve E. Szallar, Lacey M. Wood, Dennis G. Larson, Gary J. Luckasen, Matthew S. Hickey & Christopher Bell. (2014) Regulators of Human White Adipose Browning: Evidence for Sympathetic Control and Sexual Dimorphic Responses to Sprint Interval Training. PLoS ONE 9:3, pages e90696.
Crossref
Crossref
P. J. Antonellis, A. Kharitonenkov & A. C. Adams. (2014) Physiology and Endocrinology Symposium: FGF21: Insights into mechanism of action from preclinical studies1,2. Journal of Animal Science 92:2, pages 407-413.
Crossref
Crossref
E B Nygaard, C L Møller, P Kievit, K L Grove & B Andersen. (2013) Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta). International Journal of Obesity 38:2, pages 183-191.
Crossref
Crossref
Kwi-Hyun BaeJung-Guk KimKeun-Gyu Park. (2014) Transcriptional Regulation of Fibroblast Growth Factor 21 Expression. Endocrinology and Metabolism 29:2, pages 105.
Crossref
Crossref
Xiao-shan Wan, Xiang-hong Lu, Ye-cheng Xiao, Yuan Lin, Hong Zhu, Ting Ding, Ying Yang, Yan Huang, Yi Zhang, Yan-Long Liu, Zhu-mei Xu, Jian Xiao & Xiao-kun Li. (2014) ATF4- and CHOP-Dependent Induction of FGF21 through Endoplasmic Reticulum Stress. BioMed Research International 2014, pages 1-9.
Crossref
Crossref
Mohammad Hossein Salehi, Behnam Kamalidehghan, Massoud Houshmand, Omid Aryani, Majid Sadeghizadeh & Mir Majid Mossalaeie. (2013) Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia). Molecular Biology Reports 40:11, pages 6495-6499.
Crossref
Crossref
Leonard Guarente. (2013) Calorie restriction and sirtuins revisited. Genes & Development 27:19, pages 2072-2085.
Crossref
Crossref
Mingxun Li, Xiaomei Sun, Liushuai Hua, Xinsheng Lai, Xianyong Lan, Chuzhao Lei, Chunlei Zhang, Xinglei Qi & Hong Chen. (2013) SIRT1 gene polymorphisms are associated with growth traits in Nanyang cattle. Molecular and Cellular Probes 27:5-6, pages 215-220.
Crossref
Crossref
Eric S. Muise, Sandra Souza, An Chi, Yejun Tan, Xuemei Zhao, Franklin Liu, Qing Dallas-yang, Margaret Wu, Tim Sarr, Lan Zhu, Hongbo Guo, Zhihua Li, Wenyu Li, Weiwen Hu, Guoqiang Jiang, Cloud P. Paweletz, Ronald C. Hendrickson, John R. Thompson, James Mu, Joel P. Berger & Huseyin Mehmet. (2013) Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute In Vivo Administration of Fibroblast Growth Factor 21. PLoS ONE 8:9, pages e73011.
Crossref
Crossref
Andrew C. Adams, Tamer Coskun, Christine C. Cheng, Libbey S. O′Farrell, Susan L. DuBois & Alexei Kharitonenkov. (2013) Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones. Molecular Metabolism 2:3, pages 205-214.
Crossref
Crossref
Susan Kralisch, Anke Tönjes, Kerstin Krause, Judit Richter, Ulrike Lossner, Peter Kovacs, Thomas Ebert, Matthias Blüher, Michael Stumvoll & Mathias Fasshauer. (2013) Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans. Journal of Endocrinology 216:2, pages 135-143.
Crossref
Crossref
Elisa Benetti, Raffaella Mastrocola, Mara Rogazzo, Fausto Chiazza, Manuela Aragno, Roberto Fantozzi, Massimo Collino & Marco A. Minetto. (2013)
High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR-
δ
Agonism
. Mediators of Inflammation 2013, pages 1-12.
Crossref
Crossref
Laura M. Bond & James M. Ntambi. 2013. Stearoyl-CoA Desaturase Genes in Lipid Metabolism. Stearoyl-CoA Desaturase Genes in Lipid Metabolism
131
140
.
Indriyanti Rafi Sukmawati & Andi Wijaya. (2012) Molecular Regulators of Metabolism and Cardiometabolic Disease. The Indonesian Biomedical Journal 4:3, pages 129.
Crossref
Crossref
Claudia Cicione, Chiara Degirolamo & Antonio Moschetta. (2012) Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver. Hepatology 56:6, pages 2404-2411.
Crossref
Crossref
Yanlong Liu, Chunhong Wang, Yuhua Wang, Zhenhua Ma, Jian Xiao, Craig McClain, Xiaokun Li & Wenke Feng. (2012) Cobalt chloride decreases fibroblast growth factor-21 expression dependent on oxidative stress but not hypoxia-inducible factor in Caco-2 cells. Toxicology and Applied Pharmacology 264:2, pages 212-221.
Crossref
Crossref
Pedro Iglesias, Rafael Selgas, Sara Romero & Juan J Díez. (2012) MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. European Journal of Endocrinology 167:3, pages 301-309.
Crossref
Crossref
Julieta Díaz-Delfín, Elayne Hondares, Roser Iglesias, Marta Giralt, Carme Caelles & Francesc Villarroya. (2012) TNF-α Represses β-Klotho Expression and Impairs FGF21 Action in Adipose Cells: Involvement of JNK1 in the FGF21 Pathway. Endocrinology 153:9, pages 4238-4245.
Crossref
Crossref
Xunshan Ding, Jamie Boney-Montoya, Bryn M. Owen, Angie L. Bookout, Katie Colbert Coate, David J. Mangelsdorf & Steven A. Kliewer. (2012) βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism. Cell Metabolism 16:3, pages 387-393.
Crossref
Crossref
Daniel Cuevas-Ramos, Carlos A. Aguilar-Salinas & Francisco J. Gómez-Pérez. (2012) Metabolic actions of fibroblast growth factor 21. Current Opinion in Pediatrics 24:4, pages 523-529.
Crossref
Crossref
Li Qiang, Liheng Wang, Ning Kon, Wenhui Zhao, Sangkyu Lee, Yiying Zhang, Michael Rosenbaum, Yingming Zhao, Wei Gu, Stephen R. Farmer & Domenico Accili. (2012) Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ. Cell 150:3, pages 620-632.
Crossref
Crossref
Xuan Ge, Yu Wang, Karen SL Lam & Aimin Xu. (2012) Metabolic actions of FGF21: molecular mechanisms and therapeutic implications. Acta Pharmaceutica Sinica B 2:4, pages 350-357.
Crossref
Crossref
Ruben NogueirasKirk M. HabeggerNilika ChaudharyBrian FinanAlexander S. BanksMarcelo O. DietrichTamas L. HorvathDavid A. SinclairPaul T. PflugerMatthias H. Tschöp. (2012) Sirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism. Physiological Reviews 92:3, pages 1479-1514.
Crossref
Crossref
G. Schlegel, R. Ringseis, J. Keller, F. J. Schwarz, W. Windisch & K. Eder. (2012) Expression of fibroblast growth factor 21 in the liver of dairy cows in the transition period and during lactation. Journal of Animal Physiology and Animal Nutrition, pages no-no.
Crossref
Crossref
Takeshi Kobayashi & Ko Fujimori. (2012) Very long-chain-fatty acids enhance adipogenesis through coregulation of Elovl3 and PPARγ in 3T3-L1 cells. American Journal of Physiology-Endocrinology and Metabolism 302:12, pages E1461-E1471.
Crossref
Crossref
Kenneth R. Feingold, Carl Grunfeld, Josef G. Heuer, Akanksha Gupta, Martin Cramer, Tonghai Zhang, Judy K. Shigenaga, Sophie M. Patzek, Zoe W. Chan, Arthur Moser, Holly Bina & Alexei Kharitonenkov. (2012) FGF21 Is Increased by Inflammatory Stimuli and Protects Leptin-Deficient ob/ob Mice from the Toxicity of Sepsis. Endocrinology 153:6, pages 2689-2700.
Crossref
Crossref
Carles CantóJohan Auwerx. (2012) FGF21 Takes a Fat Bite. Science 336:6082, pages 675-676.
Crossref
Crossref
Elizabeth Pino, Hong Wang, Meghan E. McDonald, Li Qiang & Stephen R. Farmer. (2012) Roles for Peroxisome Proliferator-activated Receptor γ (PPARγ) and PPARγ Coactivators 1α and 1β in Regulating Response of White and Brown Adipocytes to Hypoxia. Journal of Biological Chemistry 287:22, pages 18351-18358.
Crossref
Crossref
Angeliki Chalkiadaki & Leonard Guarente. (2012) Sirtuins mediate mammalian metabolic responses to nutrient availability. Nature Reviews Endocrinology 8:5, pages 287-296.
Crossref
Crossref
Mei ZhangLi ZengYou-Juan WangZhen-Mei AnBin-Wu Ying. (2012)
Associations of
Fibroblast Growth Factor 21
Gene 3′ Untranslated Region Single-Nucleotide Polymorphisms with Metabolic Syndrome, Obesity, and Diabetes in a Han Chinese Population
. DNA and Cell Biology 31:4, pages 547-552.
Crossref
Crossref
Ana Luísa De Sousa-Coelho, Pedro F. Marrero & Diego Haro. (2012) Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation. Biochemical Journal 443:1, pages 165-171.
Crossref
Crossref
Chaofeng Yang, Chengliu Jin, Xiaokun Li, Fen Wang, Wallace L. McKeehan & Yongde Luo. (2012) Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB. PLoS ONE 7:3, pages e33870.
Crossref
Crossref
Haruya Ohno, Kosaku Shinoda, Bruce M. Spiegelman & Shingo Kajimura. (2012) PPARγ agonists Induce a White-to-Brown Fat Conversion through Stabilization of PRDM16 Protein. Cell Metabolism 15:3, pages 395-404.
Crossref
Crossref
Wei Wei, Paul A. DutchakXunde Wang, Xunshan DingXueqian Wang, Angie L. Bookout, Regina Goetz, Moosa Mohammadi, Robert D. Gerard, Paul C. Dechow, David J. MangelsdorfSteven A. KliewerYihong Wan. (2012) Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. Proceedings of the National Academy of Sciences 109:8, pages 3143-3148.
Crossref
Crossref
Matthew J. Potthoff, Steven A. Kliewer & David J. Mangelsdorf. (2012) Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes & Development 26:4, pages 312-324.
Crossref
Crossref
Li Qiang & Domenico Accili. (2012) FGF21 and the Second Coming of PPARγ. Cell 148:3, pages 397-398.
Crossref
Crossref
Paul A. Dutchak, Takeshi Katafuchi, Angie L. Bookout, Jang Hyun Choi, Ruth T. Yu, David J. Mangelsdorf & Steven A. Kliewer. (2012) Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones. Cell 148:3, pages 556-567.
Crossref
Crossref
Esther Dos Santos, René Pecquery, Philippe de Mazancourt & Marie-Noëlle Dieudonné. 2012. Adiponectin. Adiponectin
187
209
.
Yang Zhao, James D. Dunbar & Alexei Kharitonenkov. 2012. Endocrine FGFs and Klothos. Endocrine FGFs and Klothos
214
228
.
Xuan Ge, Cheng Chen, Xiaoyan Hui, Yu Wang, Karen S.L. Lam & Aimin Xu. (2011) Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes. Journal of Biological Chemistry 286:40, pages 34533-34541.
Crossref
Crossref
Hongmei Yan, Mingfeng Xia, Xinxia Chang, Qiong Xu, Hua Bian, Mengsu Zeng, Shengxiang Rao, Xiuzhong Yao, Yinfang Tu, Weiping Jia & Xin Gao. (2011) Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study. PLoS ONE 6:9, pages e24895.
Crossref
Crossref
Partha Chakrabarti, Taylor English, Shakun Karki, Li Qiang, Rong Tao, Juyoun Kim, Zhijun Luo, Stephen R. Farmer & Konstantin V. Kandror. (2011) SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. Journal of Lipid Research 52:9, pages 1693-1701.
Crossref
Crossref
Tova Meshulam, Michael R. Breen, Libin Liu, Robert G. Parton & Paul F. Pilch. (2011) Caveolins/caveolae protect adipocytes from fatty acid-mediated lipotoxicity. Journal of Lipid Research 52:8, pages 1526-1532.
Crossref
Crossref
Shigeki Sugii & Ronald M. Evans. (2011) Epigenetic codes of PPARγ in metabolic disease. FEBS Letters 585:13, pages 2121-2128.
Crossref
Crossref
Susan Kralisch & Mathias Fasshauer. (2011) Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease. Current Opinion in Clinical Nutrition and Metabolic Care 14:4, pages 354-359.
Crossref
Crossref
Yun Chau Long & Alexei Kharitonenkov. (2011) Hormone-like fibroblast growth factors and metabolic regulation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:7, pages 791-795.
Crossref
Crossref
Eleni M Domouzoglou & Eleftheria Maratos-Flier. (2011) Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis. The American Journal of Clinical Nutrition 93:4, pages 901S-905S.
Crossref
Crossref
Ingrid C. Gaemers, Jan M. Stallen, Cindy Kunne, Christian Wallner, Jochem van Werven, Aart Nederveen & Wouter H. Lamers. (2011) Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:4, pages 447-458.
Crossref
Crossref
Liang Bai, Yuzhi Jia, Navin Viswakarma, Jiansheng Huang, Aurore Vluggens, Nathan E. Wolins, Nadereh Jafari, M. Sambasiva Rao, Jayme Borensztajn, Gongshe Yang & Janardan K. Reddy. (2011) Transcription coactivator mediator subunit MED1 Is required for the development of fatty liver in the mouse. Hepatology 53:4, pages 1164-1174.
Crossref
Crossref
Alexei Kharitonenkov & Philip Larsen. (2011) FGF21 reloaded: challenges of a rapidly growing field. Trends in Endocrinology & Metabolism 22:3, pages 81-86.
Crossref
Crossref
Qiang Tong. 2011. Metabolic Syndrome. Metabolic Syndrome
391
422
.
Radmila Micanovic, James D. Dunbar & Alexei Kharitonenkov. 2011. Metabolic Syndrome. Metabolic Syndrome
377
389
.
Yasar Colak, Oguzhan Ozturk, Ebubekir Senates, Ilyas Tuncer, Elif Yorulmaz, Gupse Adali, Levent Doganay & Feruze Yilmaz Enc. (2011) SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Medical Science Monitor 17:5, pages HY5-HY9.
Crossref
Crossref
Antonio Paolo Beltrami, Daniela Cesselli & Carlo Alberto Beltrami. (2011) At the stem of youth and health. Pharmacology & Therapeutics 129:1, pages 3-20.
Crossref
Crossref
Akiko Satoh, Liana Stein & Shin Imai. 2011. Histone Deacetylases: the Biology and Clinical Implication. Histone Deacetylases: the Biology and Clinical Implication
125
162
.
Damir Zach‐Avec, Annelie Brolinson, Rachel M. Fisher, Claes Carneheim, Robert I. Csikasz, Justine Bertrand‐Michel, Jan Borén, Hervé Guillou, Mats Rudling & Anders Jacobsson. (2010) Ablation of the very‐long‐chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet‐induced obesity. The FASEB Journal 24:11, pages 4366-4377.
Crossref
Crossref
Mary D. L. Chau, Jiaping Gao, Qing Yang, Zhidan Wu & Jesper Gromada. (2010) Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway. Proceedings of the National Academy of Sciences 107:28, pages 12553-12558.
Crossref
Crossref
Kazuhiro Eto, Bayasgalan Tumenbayar, Shu-ichi Nagashima, Fumiko Tazoe, Michiaki Miyamoto, Manabu Takahashi, Akihiko Ando, Kenta Okada, Hiroaki Yagyu & Shun Ishibashi. (2010) Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes. Diabetes Research and Clinical Practice 89:1, pages 52-57.
Crossref
Crossref
Nicolas Rotman & Walter Wahli. (2010) PPAR Modulation of Kinase-Linked Receptor Signaling in Physiology and Disease. Physiology 25:3, pages 176-185.
Crossref
Crossref
Shin-ichiro Imai & Leonard Guarente. (2010) Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends in Pharmacological Sciences 31:5, pages 212-220.
Crossref
Crossref
Mark J. Holness, Paul W. Caton & Mary C. Sugden. (2010) Acute and long-term nutrient-led modifications of gene expression: Potential role of SIRT1 as a central co-ordinator of short and longer-term programming of tissue function. Nutrition 26:5, pages 491-501.
Crossref
Crossref
Yariv Kanfi, Victoria Peshti, Reuven Gil, Shoshana Naiman, Liat Nahum, Eran Levin, Noga Kronfeld-Schor & Haim Y. Cohen. (2010) SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 9:2, pages 162-173.
Crossref
Crossref
Cecile VernochetKathryn E. Davis, Philipp E. Scherer & Stephen R. Farmer. (2010) Mechanisms Regulating Repression of Haptoglobin Production by Peroxisome Proliferator-Activated Receptor-γ Ligands in Adipocytes. Endocrinology 151:2, pages 586-594.
Crossref
Crossref
Steven A Kliewer & David J Mangelsdorf. (2010) Fibroblast growth factor 21: from pharmacology to physiology. The American Journal of Clinical Nutrition 91:1, pages 254S-257S.
Crossref
Crossref
Stephen R. Farmer. 2010. Novel Insights into Adipose Cell Functions. Novel Insights into Adipose Cell Functions
93
100
.
Gui-Ping REN, Lu LI, Guo-Peng SUN, Yu-Ting HOU, Wen-Fei WANG & De-Shan LI. (2009) Fibroblast Growth Factor Receptor-2 Involved in FGF-21-mediated Glucose Metabolism*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 2009:2, pages 165-174.
Crossref
Crossref
Michael K. BadmanAnja Koester, Jeffrey S. FlierAlexei Kharitonenkov & Eleftheria Maratos-Flier. (2009) Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis. Endocrinology 150:11, pages 4931-4940.
Crossref
Crossref
Charis L. Johnson, Jacqueline Y. Weston, Sami A. Chadi, Elena N. Fazio, Murray W. Huff, Alexei Kharitonenkov, Anja Köester & Christopher L. Pin. (2009) Fibroblast Growth Factor 21 Reduces the Severity of Cerulein-Induced Pancreatitis in Mice. Gastroenterology 137:5, pages 1795-1804.
Crossref
Crossref
Shin-ichiro Imai. (2009) From heterochromatin islands to the NAD World: A hierarchical view of aging through the functions of mammalian Sirt1 and systemic NAD biosynthesis. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:10, pages 997-1004.
Crossref
Crossref
Katsumi Iizuka, Jun Takeda & Yukio Horikawa. (2009) Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes. FEBS Letters 583:17, pages 2882-2886.
Crossref
Crossref
Ke Li, Ling Li, Mengliu Yang, Haihong Zong, Hua Liu & Gangyi Yang. (2009) Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus. European Journal of Endocrinology 161:3, pages 391-395.
Crossref
Crossref
Constantinos Christodoulides, Pamela Dyson, Dennis Sprecher, Kostas Tsintzas & Fredrik Karpe. (2009) Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man. The Journal of Clinical Endocrinology & Metabolism 94:9, pages 3594-3601.
Crossref
Crossref
Fengxia Liang, Shinji Kume & Daisuke Koya. (2009) SIRT1 and insulin resistance. Nature Reviews Endocrinology 5:7, pages 367-373.
Crossref
Crossref
Mikael Rydén. (2009) Fibroblast growth factor 21: an overview from a clinical perspective. Cellular and Molecular Life Sciences 66:13, pages 2067-2073.
Crossref
Crossref
Balaji Shoba, Zin Mar Lwin, Lo Soo Ling, Boon-Huat Bay, George W. Yip & Srinivasan Dinesh Kumar. (2009) Function of Sirtuins in Biological Tissues. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 292:4, pages 536-543.
Crossref
Crossref
Andrew Beenken & Moosa Mohammadi. (2009) The FGF family: biology, pathophysiology and therapy. Nature Reviews Drug Discovery 8:3, pages 235-253.
Crossref
Crossref
Shin-ichiro Imai. (2009) The NAD World: A New Systemic Regulatory Network for Metabolism and Aging—Sirt1, Systemic NAD Biosynthesis, and Their Importance. Cell Biochemistry and Biophysics 53:2, pages 65-74.
Crossref
Crossref
Hiroshi Kurosu & Makoto Kuro-o. (2009) The Klotho gene family as a regulator of endocrine fibroblast growth factors. Molecular and Cellular Endocrinology 299:1, pages 72-78.
Crossref
Crossref
Hiroshi Kurosu & Makoto Kuro-o. (2009) Endocrine fibroblast growth factors as regulators of metabolic homeostasis. BioFactors 35:1, pages 52-60.
Crossref
Crossref
Tamer Coskun, Holly A. Bina, Michael A. Schneider, James D. Dunbar, Charlie C. Hu, Yanyun Chen, David E. Moller & Alexei Kharitonenkov. (2008) Fibroblast Growth Factor 21 Corrects Obesity in Mice. Endocrinology 149:12, pages 6018-6027.
Crossref
Crossref
Katsutaka Oishi, Daisuke Uchida & Norio Ishida. (2008)
Circadian expression of
FGF21
is induced by PPARα activation in the mouse liver
. FEBS Letters 582:25-26, pages 3639-3642.
Crossref
Crossref
Eric S. Muise, Barbara Azzolina, David W. Kuo, Mohamed El-Sherbeini, Yejun Tan, Xiling Yuan, James Mu, John R. Thompson, Joel P. Berger & Kenny K. Wong. (2008) Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor γ and Altered Metabolic States. Molecular Pharmacology 74:2, pages 403-412.
Crossref
Crossref
Jerome N Feige & Johan Auwerx. (2008) Transcriptional targets of sirtuins in the coordination of mammalian physiology. Current Opinion in Cell Biology 20:3, pages 303-309.
Crossref
Crossref